Lv4
440 积分 2024-03-13 加入
Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study
10天前
已关闭
Ocular Adverse Events Associated with Pegcetacoplan and Avacincaptad Pegol for Geographic Atrophy: A Population-Based Pharmacovigilance Study
10天前
已关闭
Postmarketing safety analysis of upadacitinib in atopic dermatitis: A Food and Drug Administration adverse reporting system review of boxed warning-related adverse events
10天前
已完结
Keeping a balance in chronic lymphocytic leukemia (CLL) patients taking ibrutinib: ibrutinib-associated adverse events and their management based on drug interactions
20天前
已完结
Cutaneous botryomycosis mimicking ecthyma gangrenosum in a patient treated with ibrutinib
20天前
已完结
Management of adverse effects/toxicity of ibrutinib
20天前
已完结
Approach to Richter transformation of chronic lymphocytic leukemia in the era of novel therapies
20天前
已完结
Diagnosis and Treatment of Chronic Lymphocytic Leukemia: A Review
20天前
已完结
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
20天前
已完结
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease
20天前
已完结
皖公网安备34019202002308
